These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


125 related items for PubMed ID: 22267446

  • 1. Fluorodeoxyglucose-induced allergic reaction: a case report.
    Codreanu I, Dasanu CA, Weinstein GS, Divgi C.
    J Oncol Pharm Pract; 2013 Mar; 19(1):86-8. PubMed ID: 22267446
    [Abstract] [Full Text] [Related]

  • 2. Metastatic small cell neuroendocrine carcinoma of the pyriform sinus evaluated by ¹⁸F-FDG PET/CT.
    Treglia G, Bongiovanni M, Paone G, Ruberto T, Parvex-Leoni S, Giovanella L.
    Rev Esp Med Nucl Imagen Mol; 2015 Mar; 34(2):125-7. PubMed ID: 25018134
    [No Abstract] [Full Text] [Related]

  • 3. Potential for truncating the scan length of restaging FDG-PET/CT after chemoradiotherapy in head and neck squamous cell carcinoma.
    Huang YT, Ravi Kumar AS.
    Nucl Med Commun; 2012 May; 33(5):503-8. PubMed ID: 22262244
    [Abstract] [Full Text] [Related]

  • 4. Early prediction of response to cetuximab and radiotherapy by FDG-PET/CT for the treatment of a locoregionally advanced squamous cell carcinoma of the hypopharynx.
    Grybauskas M, Daisne JF, Aleknavičius E, Burneckis A.
    Medicina (Kaunas); 2014 May; 50(4):245-8. PubMed ID: 25458962
    [Abstract] [Full Text] [Related]

  • 5. 18F-FDG PET/CT for detecting distant metastases in patients with recurrent head and neck squamous cell carcinoma.
    Yi JS, Kim JS, Lee JH, Choi SH, Nam SY, Kim SY, Roh JL.
    J Surg Oncol; 2012 Nov; 106(6):708-12. PubMed ID: 22674652
    [Abstract] [Full Text] [Related]

  • 6. Improving the accuracy of target volume delineation by combined use of computed tomography, magnetic resonance imaging and positron emission tomography in head and neck carcinomas.
    Chauhan D, Rawat S, Sharma MK, Ahlawat P, Pal M, Gupta G, Dewan A, Gupta M, Sharma S, Dodagoudar C, Pahuja A, Mitra S, Sharma SK.
    J Cancer Res Ther; 2015 Nov; 11(4):746-51. PubMed ID: 26881512
    [Abstract] [Full Text] [Related]

  • 7. Characteristics and Limitations of FDG PET/CT for Imaging of Squamous Cell Carcinoma of the Head and Neck: A Comprehensive Review of Anatomy, Metastatic Pathways, and Image Findings.
    Plaxton NA, Brandon DC, Corey AS, Harrison CE, Karagulle Kendi AT, Halkar RK, Barron BJ.
    AJR Am J Roentgenol; 2015 Nov; 205(5):W519-31. PubMed ID: 26496574
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Unusual solitary splenic metastasis from pyriform fossa carcinoma detected by FDG-PET.
    Abhyankar A, Desai SB, Asopa RV, Basu S.
    Indian J Cancer; 2015 Nov; 52(4):524-5. PubMed ID: 26960464
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Role of FDG-PET/CT in staging and follow-up of head and neck squamous cell carcinoma.
    Mak D, Corry J, Lau E, Rischin D, Hicks RJ.
    Q J Nucl Med Mol Imaging; 2011 Oct; 55(5):487-99. PubMed ID: 22019706
    [Abstract] [Full Text] [Related]

  • 14. Diagnostic value of only 18F-fluorodeocyglucose positron emission tomography/computed tomography-positive lymph nodes in head and neck squamous cell carcinoma.
    Lee SH, Huh SH, Jin SM, Rho YS, Yoon DY, Park CH.
    Otolaryngol Head Neck Surg; 2012 Oct; 147(4):692-8. PubMed ID: 22535915
    [Abstract] [Full Text] [Related]

  • 15. Pretreatment positron emission tomography with [18F]fluorodeoxyglucose for head and neck squamous cancer.
    Paleri V, Zammit-Maempel I.
    J Clin Oncol; 2010 Oct 01; 28(28):e515. PubMed ID: 20606098
    [No Abstract] [Full Text] [Related]

  • 16. Is image registration of fluorodeoxyglucose-positron emission tomography/computed tomography for head-and-neck cancer treatment planning necessary?
    Fried D, Lawrence M, Khandani AH, Rosenman J, Cullip T, Chera BS.
    Int J Radiat Oncol Biol Phys; 2012 Nov 01; 84(3):748-54. PubMed ID: 22414285
    [Abstract] [Full Text] [Related]

  • 17. ¹⁸F-FDG-PET imaging in radiotherapy tumor volume delineation in treatment of head and neck cancer.
    Delouya G, Igidbashian L, Houle A, Bélair M, Boucher L, Cohade C, Beaulieu S, Filion EJ, Coulombe G, Hinse M, Martel C, Després P, Nguyen-Tan PF.
    Radiother Oncol; 2011 Dec 01; 101(3):362-8. PubMed ID: 21885143
    [Abstract] [Full Text] [Related]

  • 18. Intratumor Textural Heterogeneity on Pretreatment (18)F-FDG PET Images Predicts Response and Survival After Chemoradiotherapy for Hypopharyngeal Cancer.
    Oh JS, Kang BC, Roh JL, Kim JS, Cho KJ, Lee SW, Kim SB, Choi SH, Nam SY, Kim SY.
    Ann Surg Oncol; 2015 Aug 01; 22(8):2746-54. PubMed ID: 25487968
    [Abstract] [Full Text] [Related]

  • 19. Correlation between fluorodeoxyglucose hotspots on pretreatment positron emission tomography/CT and preferential sites of local relapse after chemoradiotherapy for head and neck squamous cell carcinoma.
    Chaput A, Calais J, Robin P, Thureau S, Bourhis D, Modzelewski R, Schick U, Vera P, Salaün PY, Abgral R.
    Head Neck; 2017 Jun 01; 39(6):1155-1165. PubMed ID: 28263422
    [Abstract] [Full Text] [Related]

  • 20. Can "early" and "late"18F-FDG PET-CT be used as prognostic factors for the clinical outcome of patients with locally advanced head and neck cancer treated with radio-chemotherapy?
    Castaldi P, Rufini V, Bussu F, Miccichè F, Dinapoli N, Autorino R, Lago M, De Corso E, Almadori G, Galli J, Paludetti G, Giordano A, Valentini V.
    Radiother Oncol; 2012 Apr 01; 103(1):63-8. PubMed ID: 22459579
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.